journal article·2020-08

Hypoxia/pH dual-responsive nitroimidazole-modified chitosan/rose bengal derivative nanoparticles for enhanced photodynamic anticancer therapy

Xudong Li, Jun Wang, Ranran Cui, Dekang Xu, Lisheng Zhu, Ziying Li, Haijun Chen, Yu Gao, Lee Jia

Dyes and Pigments· Volume 179
Publisher page

Abstract

Abstract Most of the traditional photosensitizers (PSs) used in photodynamic therapy (PDT) have poor tumor targeting and phototoxic side effects. Drug delivery systems can be designed to be triggered to release payload PSs in response to intracellular hypoxia and acidic environment of tumors with controllable photoactivity to achieve enhanced therapeutic effects with minimal side-effects. In this work, we synthesized nitroimidazole-modified chitosan (Cs-NA) and prepared Cs-NA/rose bengal ω-carboxyheptyl ester (a rose bengal derivative, RBD) complex nanoparticles (Cs-NA/RBD) for pH and hypoxia double-responsive RBD delivery. Cs-NA/RBD possessed appropriate particle size of about 86.9 nm and zeta potential of +33.4 mV, showed good stability in cell culture medium, and demonstrated increased accumulative release at acidic and hypoxia condition by about 60% compared to that at neutral pH. The cellular uptake efficiency of Cs-NA/RBD in non-small cell lung cancer PC9 cells increased more than 10 times compared with Cs-NA/RB. The anti-proliferative effects and the generation of reactive oxygen species (ROS) in PC9 cells indicated the notable photodynamic therapeutic effects of Cs-NA/RBD. These results suggested that Cs-NA/RBD could be a promising nanoplatform for enhanced controllable photodynamic anticancer therapy.
Source: openaire · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Nanoparticle-Based Drug Delivery · Photodynamic Therapy Research Studies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (49)

Show source-provided references
1. Rose bengal staining as an assessment of ocular surface damage and recovery in dry eye disease-a review10.1016/j.clae.2013.07.008 ↗
2. The food colorant erythrosine is a promiscuous protein-protein interaction inhibitor10.1016/j.bcp.2010.12.020 ↗
3. A compilation of singlet oxygen yields from biologically relevant molecules10.1111/j.1751-1097.1999.tb08240.x ↗
4. Topical rose bengal: pre-clinical evaluation of pharmacokinetics and safety10.1002/lsm.10138 ↗
6. Synthesis of amphiphilic derivatives of rose bengal and their tumor accumulation10.1021/bc060189p ↗
7. Microbubble-sonosensitiser conjugates as therapeutics in sonodynamic therapy10.1039/c2cc33913g ↗
8. Synthesis and biological characterization of novel rose bengal derivatives with improved amphiphilicity for sono-photodynamic therapy10.1016/j.ejmech.2017.12.091 ↗
9. Erlotinib-guided self-assembled trifunctional click nanotheranostics for distinguishing druggable mutations and synergistic therapy of nonsmall cell lung cancer10.1021/acs.molpharmaceut.8b00561 ↗
10. A hematoporphyrin and indocyanine green co-delivery system with NIR triggered-controllable photoactivities for photodynamic therapy10.1016/j.dyepig.2018.02.034 ↗
11. A hypoxia-responsive albumin-based nanosystem for deep tumor penetration and excellent therapeutic efficacy10.1002/adma.201901513 ↗
12. Stimuli-responsive nanocarriers for drug delivery10.1038/nmat3776 ↗
13. pH-responsive drug-delivery systems10.1002/asia.201402715 ↗
14. Peptide dendrimer–doxorubicin conjugate-based nanoparticle as an enzyme-responsive drug delivery system for cancer therapy10.1002/adhm.201300601 ↗
15. Hypoxia-responsive polymeric nanoparticles for tumor-targeted drug delivery10.1016/j.biomaterials.2013.11.022 ↗
16. Mesoporous silica nanoparticles end-capped with collagen: redox-responsive nanoreservoirs for targeted drug delivery10.1002/anie.201005061 ↗
17. Tumor microenvironment-responsive nanoparticles for cancer theragnostic applications10.1186/s40824-018-0132-z ↗
18. Hypoxia in cancer: significance and impact on clinical outcome, Cancer Metastasis
19. High selectivity imaging of nitroreductase using a near-infrared fluorescence probe in hypoxic tumor10.1039/c3cc38980d ↗
20. Novel fluorescent markers for hypoxic cells of naphthalimides with two heterocyclic side chains for bioreductive binding10.1016/j.bmc.2005.12.012 ↗
21. Light-activated hypoxia-responsive nanocarriers for enhanced anticancer therapy10.1002/adma.201505869 ↗
22. Hypoxia-targeting, tumor microenvironment responsive nanocluster bomb for radical-enhanced radiotherapy10.1021/acsnano.7b04737 ↗
23. Hypoxia-responsive polymeric nanoparticles for tumor-targeted drug delivery10.1016/j.biomaterials.2013.11.022 ↗
24. Significance of nitroimidazole compounds and hypoxia-inducible factor-1 for imaging tumor hypoxia10.1111/j.1349-7006.2009.01195.x ↗
25. Recent advances in chitosan-based nanoparticulate pulmonary drug delivery10.1039/C6NR03256G ↗
26. Chitosan and its derivatives as vehicles for drug delivery10.1080/10717544.2017.1399305 ↗
27. Self-assembled chitosan/rose bengal derivative nanoparticles for targeted sonodynamic therapy: preparation and tumor accumulation10.1039/C4RA15347B ↗
28. The effect of extracellular pH on radiosensitization by misonidazole and acidic or basic analogues10.1080/09553008514550881 ↗
29. Indocyanine green-encapsulated erlotinib modified chitosan nanoparticles for targeted chemo-photodynamic therapy of lung cancer cells10.1016/j.dyepig.2019.107588 ↗
30. Hypoxia-inducible bidirectional shRNA expression vector delivery using PEI/chitosan-TBA copolymers for colorectal Cancer gene therapy10.1016/j.lfs.2018.04.011 ↗
31. Chitin and chitosan polymers: chemistry, solubility and fiber formation10.1016/j.progpolymsci.2009.04.001 ↗
32. Hypoxia- and singlet oxygen-responsive chemo-photodynamic Micelles featured with glutathione depletion and aldehyde production10.1039/C8BM01042K ↗
33. Apoptosis, paraptosis and autophagy: death and survival pathways associated with photodynamic therapy10.1111/php.12952 ↗
34. Photodynamic therapy and pain: a systematic review10.1016/j.pdpdt.2017.07.002 ↗
35. Prodrug-embedded angiogenic vessel-targeting nanoparticle: a positive feedback amplifier in hypoxia-induced chemo-photo therapy10.1016/j.biomaterials.2017.08.032 ↗
36. Cyclometalated iridium(III)-Complex-Based micelles for glutathione-responsive targeted chemotherapy and photodynamic therapy10.1021/acsami.7b09506 ↗
37. Current multistage drug delivery systems based on the tumor microenvironment10.7150/thno.16684 ↗
38. Hypoxia-responsive mesoporous nanoparticles for doxorubicin delivery10.3390/polym10040390 ↗
39. Development of hypoxia-triggered prodrug micelles as doxorubicin carriers for tumor therapy10.1039/C4RA14875D ↗
40. Apoptosis and associated phenomena as a determinants of the efficacy of photodynamic therapy10.1039/c4pp00413b ↗
41. Physical principles of nanoparticle cellular endocytosis10.1021/acsnano.5b03184 ↗
42. PNA-rose bengal conjugates as efficient DNA photomodulators10.1021/acs.bioconjchem.5b00406 ↗
43. Accumulation mechanism of 2-Nitroimidazole-based hypoxia imaging probes revealed by imaging mass spectrometry10.1248/yakushi.18-00146 ↗
44. In vitro and in vivo clearance of Rose Bengal Acetate-PhotoDynamic Therapy-induced autophagic and apoptotic cells10.1177/1535370213494552 ↗
45. Rose Bengal acetate photodynamic therapy (RBAc-PDT) induces exposure and release of Damage-Associated Molecular Patterns (DAMPs) in human HeLa cells10.1371/journal.pone.0105778 ↗
46. Comparative analysis of apoptosis measured by Hoechst and flow cytometry in non-Hodgkin's lymphomas10.1002/(SICI)1097-0320(19980501)32:1<44::AID-CYTO6>3.0.CO;2-F ↗
47. Combination of photodynamic therapy (PDT) and anti-tumor immunity in cancer therapy10.1007/s40005-017-0377-x ↗
48. Direct toxicity of Rose Bengal in MCF-7 cell line: role of apoptosis10.1016/j.fct.2009.01.018 ↗
49. Biomedical applications of photo- and sono-activated rose bengal: a review